High-LMR | Low-LMR | p value | |
---|---|---|---|
Patient population (n) | 142 | 66 | |
Demographic data | |||
Age (years) | 59 (13) | 63 (8.25) | 0.005 |
Sex, male (n) | 86 (60.6%) | 49 (74.2%) | 0.048 |
Medical history | |||
Hypertension (n) | 42 (29.6%) | 33 (50.0%) | 0.004 |
Smoking (n) | 62 (43.7%) | 32 (48.5%) | 0.488 |
Diabetes (n) | 14 (9.9%) | 4 (6.1%) | 0.372 |
Post-calcific stenotic aortic dilatation (n) | 28 (19.7%) | 29 (43.9%) | < 0.001 |
Maximal diameter of the ascending aorta (cm) | 4.35 (1.03) | 4.76 (1.60) | 0.003 |
Tricuspid aortic valve(n) | 61 (43.0%) | 52 (78.8%) | < 0.001 |
Baseline echocardiography | |||
LVEDD (cm) | 5.41 (1.43) | 6.29 (1.41) | < 0.001 |
LVEF (%) | 60 (7) | 58 (7.5) | 0.031 |
Preoperative laboratory tests | |||
Leukocyte (109/L) | 5.74 (1.93) | 6.16 (1.90) | 0.020 |
Neutrophil (109/L) | 3.33 (1.48) | 3.73 (1.26) | 0.004 |
Platelet (109/L) | 193 (69) | 187 (85.25) | 0.818 |
Monocyte (109/L) | 0.47 (0.20) | 0.79 (0.43) | < 0.001 |
Lymphocyte (109/L) | 1.88 (0.51) | 1.54 (0.67) | < 0.001 |
LDL-C (mmol/L) | 2.87 (1.18) | 2.68 (1.12) | 0.101 |
CRP (mg/L) | 0.77 (1.43) | 1.18 (2.07) | 0.134 |
MPV (fl) | 10.90 (1.30) | 10.60 (1.15) | 0.287 |